{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:23:12Z","timestamp":1763194992952,"version":"3.45.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06610-9","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T07:12:36Z","timestamp":1759821156000},"page":"5309-5322","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Routine interventions failed to provide survival benefits for early-stage major salivary gland marginal zone lymphoma in a population-based analysis"],"prefix":"10.1007","volume":"104","author":[{"given":"Jiaqi","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"6610_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.beha.2017.11.001","volume":"31","author":"I Defrancesco","year":"2018","unstructured":"Defrancesco I, Arcaini L (2018) Overview on the management of non-gastric MALT lymphomas. Best Pract Res Clin Haematol 31:57\u201364","journal-title":"Best Pract Res Clin Haematol"},{"key":"6610_CR2","unstructured":"Cook JR, Isaacson PG, Chott A et al (2017) Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (Revised 4th Edition). Lyon, France: IAR 259\u2013262"},{"key":"6610_CR3","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, Cortelazzo S, Motta T, Gospodarowicz MK, Patterson BJ et al (2003) Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 101:2489\u20132495","journal-title":"Blood"},{"key":"6610_CR4","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.12998\/wjcc.v8.i13.2717","volume":"8","author":"X Zhang","year":"2020","unstructured":"Zhang X, Wang Z (2020) Relevance on the diagnosis of malignant lymphoma of the salivary gland. World J Clin Cases 8:2717\u20132726","journal-title":"World J Clin Cases"},{"key":"6610_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/ajcp\/aqaa005","volume":"153","author":"A Travaglino","year":"2020","unstructured":"Travaglino A, Giordano C, Pace M, Varricchio S, Picardi M, Pane F, Staibano S et al (2020) Sj\u00f6gren syndrome in primary salivary gland lymphoma. Am J Clin Pathol 153:719\u2013724","journal-title":"Am J Clin Pathol"},{"key":"6610_CR6","first-page":"2050","volume":"13","author":"J Wang","year":"2020","unstructured":"Wang J, Li R, Wang Q, Chen Y, Gao T, Han R, Li N et al (2020) The clinicopathological features of Parotid lymphoma. INT J CLIN EXP PATHO 13:2050\u20132057","journal-title":"INT J CLIN EXP PATHO"},{"key":"6610_CR7","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1136\/annrheumdis-2020-217646","volume":"79","author":"E Pontarini","year":"2020","unstructured":"Pontarini E, Murray-Brown WJ, Croia C, Lucchesi D, Conway J, Rivellese F, Fossati-Jimack L et al (2020) Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sj\u00f6gren\u2019s syndrome with ectopic germinal centres and MALT lymphoma. Ann Rheum Dis 79:1588\u20131599","journal-title":"Ann Rheum Dis"},{"key":"6610_CR8","doi-asserted-by":"crossref","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888\u2013892","DOI":"10.7326\/0003-4819-89-6-888"},{"key":"6610_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/hed.23543","volume":"37","author":"A Vazquez","year":"2015","unstructured":"Vazquez A, Khan MN, Sanghvi S, Patel NR, Caputo JL, Baredes S, Eloy JA (2015) Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue of the salivary glands: a population-based study from 1994 to 2009. Head Neck 37:18\u201322","journal-title":"Head Neck"},{"key":"6610_CR10","first-page":"54","volume":"53","author":"Q Su","year":"2018","unstructured":"Su Q, Yu GY (2018) Research progress of salivary glands mucosa-associated lymphoid tissue lymphoma. Chin J Stomatol 53:54\u201359","journal-title":"Chin J Stomatol"},{"key":"6610_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1634\/theoncologist.2015-0180","volume":"20","author":"AE Jackson","year":"2015","unstructured":"Jackson AE, Mian M, Kalpadakis C, Pangalis GA, Stathis A, Porro E, Conconi A et al (2015) Extranodal marginal zone lymphoma of Mucosa-Associated lymphoid tissue of the salivary glands: A multicenter, international experience of 248 patients (IELSG 41). Oncologist 20:1149\u20131153","journal-title":"Oncologist"},{"key":"6610_CR12","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1182\/blood-2015-12-624304","volume":"127","author":"E Zucca","year":"2016","unstructured":"Zucca E, Bertoni F (2016) The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 127:2082\u20132092","journal-title":"Blood"},{"key":"6610_CR13","doi-asserted-by":"crossref","unstructured":"Sindel A, Al-Juhaishi T, Yazbeck V (2019) Marginal zone lymphoma: State-of-the-art treatment, vol 20. Curr Treat Option On p 90","DOI":"10.1007\/s11864-019-0687-5"},{"key":"6610_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","volume":"31","author":"E Zucca","year":"2020","unstructured":"Zucca E, Arcaini L, Buske C, Johnson PW, Ponzoni M, Raderer M, Ricardi U et al (2020) Marginal zone lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:17\u201329","journal-title":"Ann Oncol"},{"key":"6610_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejca.2021.05.004","volume":"152","author":"MP MacManus","year":"2021","unstructured":"MacManus MP, Roos D, O\u2019Brien P et al (2021) Prospective phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02\/ALLG NHL15. Eur J Cancer 152:129\u2013138","journal-title":"Eur J Cancer"},{"key":"6610_CR16","doi-asserted-by":"crossref","unstructured":"Ian WF, Richard VDJ, Brad K et al (2019) First-line treatment of patients with indolent non-Hodgkin lymphoma or mantle-cell lymphoma with bendamustine plus rituximab versus R-CHOP or R-CVP: results of the BRIGHT 5-year follow-up study. J Clin Oncol 37:984\u2013991","DOI":"10.1200\/JCO.18.00605"},{"key":"6610_CR17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P, Salles G et al (2000) Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. https:\/\/doi.org\/10.1182\/blood.V95.3.802.003k19_802_806","journal-title":"Blood"},{"key":"6610_CR18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.06.0723","author":"M Raderer","year":"2006","unstructured":"Raderer M, W\u00f6hrer S, Streubel B, Troch M, Turetschek K, J\u00e4ger U, Skrabs C et al (2006) Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2006.06.0723","journal-title":"J Clin Oncol"},{"key":"6610_CR19","doi-asserted-by":"crossref","unstructured":"Ahmed Ehsan A, Fahd A, Yusuf B et al (2023) Lymphomas of the salivary glands: a systematic review. Acta Otolaryngol 143:610\u2013616","DOI":"10.1080\/00016489.2023.2226689"},{"key":"6610_CR20","unstructured":"Horner M, Ries L, Krapcho M, Neyman N, Aminou R (2011) Surveillance Epidemiology and End Results (SEER) Program. wwwseercancergov"},{"key":"6610_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.beha.2017.01.002","volume":"30","author":"C Thieblemont","year":"2017","unstructured":"Thieblemont C, Zucca E (2017) Clinical aspects and therapy of gastrointestinal MALT lymphoma. Best Pract Res Clin Haematol 30:109\u2013117","journal-title":"Best Pract Res Clin Haematol"},{"key":"6610_CR22","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.1002\/cam4.2683","volume":"8","author":"L Wang","year":"2019","unstructured":"Wang L, Ye G, Liu Z, Shi L, Zhan C, Gu J, Luo R et al (2019) Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma. Cancer Med 8:7660\u20137668","journal-title":"Cancer Med"},{"key":"6610_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/bjophthalmol-2019-314008","volume":"104","author":"TG Hinds\u00f8","year":"2020","unstructured":"Hinds\u00f8 TG, Esmaeli B, Holm F, Mikkelsen LH, Rasmussen PK, Coupland SE, Finger PT et al (2020) International multicentre retrospective cohort study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol 104:357\u2013362","journal-title":"Br J Ophthalmol"},{"key":"6610_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13005-018-0186-0","volume":"15","author":"K Storck","year":"2019","unstructured":"Storck K, Brandstetter M, Keller U, Knopf A (2019) Clinical presentation and characteristics of lymphoma in the head and neck region. Head Face Med 15:1","journal-title":"Head Face Med"},{"key":"6610_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/annonc\/mds643","volume":"24","author":"M Dreyling","year":"2013","unstructured":"Dreyling M, Thieblemont C, Gallamini A, Arcaini L, Campo E, Hermine O, Kluin-Nelemans JC et al (2013) Esmo consensus conferences: guidelines on malignant lymphoma. Part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma. Ann Oncol 24:857\u2013877","journal-title":"Ann Oncol"},{"key":"6610_CR26","unstructured":"NCCN clinical practice guidelines in oncology. NonHodgkin\u2019s Lymphomas. Version 4. 2014"},{"key":"6610_CR27","doi-asserted-by":"crossref","unstructured":"Ming Y, Shu-Lang L, Chung-Wu L et al (2023) First-line antibiotic treatment in patients with localized extragastric mucosa-associated lymphoid tissue lymphoma. EJHaem 4:55\u201366","DOI":"10.1002\/jha2.608"},{"issue":"8","key":"6610_CR28","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","volume":"122","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Raderer M (2013) Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood 122(8):1350\u20131357","journal-title":"Blood"},{"issue":"20","key":"6610_CR29","doi-asserted-by":"publisher","first-page":"5207","DOI":"10.1158\/1078-0432.CCR-14-0496","volume":"20","author":"E Zucca","year":"2014","unstructured":"Zucca E, Bertoni F, Vannata B, Cavalli F (2014) Emerging role of infectious etiologies in the pathogenesis of marginal zone B-cell lymphomas. Clin Cancer Res 20(20):5207\u20135216","journal-title":"Clin Cancer Res"},{"key":"6610_CR30","doi-asserted-by":"crossref","unstructured":"Leticia Q, Falko F (2022) Turning up the heat on salivary gland MALT lymphoma. Blood 139:2094\u20132096","DOI":"10.1182\/blood.2021012624"},{"key":"6610_CR31","unstructured":"Jorge F, Dai C, Isildinha R et al (2024) Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US Population-based analysis. Blood Adv"},{"key":"6610_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ijrobp.2010.09.046","volume":"82","author":"Y Anacak","year":"2012","unstructured":"Anacak Y, Miller RC, Constantinou N et al (2012) Primary mucosa-associated lymphoid tissue lymphoma of the salivary glands: a multicenter rare cancer network study. Int J Radiat Oncol Biol Phys 82:315\u2013320","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6610_CR33","doi-asserted-by":"crossref","unstructured":"Conconi A, Martinelli G, Thi\u00e9blemont C, Ferreri AJM, Devizzi L, Peccatori F, Ponzoni M et al (2003) Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102:2741\u20132745","DOI":"10.1182\/blood-2002-11-3496"},{"issue":"3","key":"6610_CR34","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/S2352-3026(14)00021-0","volume":"1","author":"A Salar","year":"2014","unstructured":"Salar A, Domingo-Domenech E, Panizo C, Nicol\u00e1s C, Bargay J et al (2014) First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosa-associated lymphoid tissue lymphoma (MALT2008-01): a multicentre, single-arm, phase 2 trial. Lancet Haematol 1(3):e104\u2013e111","journal-title":"Lancet Haematol"},{"key":"6610_CR35","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1182\/blood-2019-126396","volume":"134","author":"SM Handunnetti","year":"2019","unstructured":"Handunnetti SM, Khot A, Anderson MA et al (2019) Safety and efficacy of ibrutinib in combination with venetoclax in patients with marginal zone lymphoma: preliminary results from an open label. Phase II study. Blood 134:3999","journal-title":"Blood"},{"key":"6610_CR36","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.7906","author":"RH Advani","year":"2013","unstructured":"Advani RH, Buggy JJ, Sharman JP, Smith SM, Boyd TE, Grant B, Kolibaba KS et al (2013) Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2012.42.7906","journal-title":"J Clin Oncol"},{"key":"6610_CR37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583","author":"AK Gopal","year":"2014","unstructured":"Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ, Flinn IW et al (2014) PI3K\u03b4 inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa1314583","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06610-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06610-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T08:19:29Z","timestamp":1763194769000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06610-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["6610"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06610-9","relation":{},"ISSN":["1432-0584"],"issn-type":[{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u00a0An ethics statement is not required for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}